Abstract
Acute lymphoid leukemia (ALL) is the main cancer affecting children. Despite the high cure rates achieved in recent decades, and even with great effort in the search for new therapeutic strategies, approximately 20 to 30% of cases relapse from the disease, due to resistance to chemotherapy. Although some genetic subgroups of ALL are associated with a peculiar drug resistance/sensitivity p…